Ostatní
Návod 
Zymeworks Inc.
ZYME
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.3B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-20%
ROA
-16%
PE
-22
PS
17
Cena 1R
9-28
⌀ Cena
16.53
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
04-03-2026
Poslední dividenda
Profil
Zymeworks Inc., biofarmaceutická společnost v klinickém stadiu, objevuje, vyvíjí a komercializuje bioterapeutické přípravky pro léčbu rakoviny. Mezi hlavní kandidáty společnosti patří zanidatamab, nová bispecifická protilátka, která se nachází v klinických studiích fáze 1 a fáze 2 pro léčbu biliárního traktu, adenokarcinomu gastroezofageálního traktu, karcinomu prsu a kolorektálního karcinomu, a ZW49, konjugát protilátek a léků proti lidskému epidermálnímu růstovému faktoru 2 (HER2), který je součástí klinické studie fáze 1 pro léčbu pokročilých nebo metastazujících karcinomů s expresí HER2. Společnost má strategické partnerství se společností Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; BeiGene, Ltd.; a Exelixis, Inc. Má také licenční a výzkumnou spolupráci s LEO Pharma A/S na výzkumu, vývoji a komercializaci biskupských protilátek; a Iconic Therapeutics, Inc. Zymeworks Inc. zapsána v obchodním rejstříku v roce 2003 a má sídlo ve Vancouveru v Kanadě.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
299
Založení
2017-04-28
Podobné společnosti
$ 5.69
+ $ 0.10
$ 21.54
- $ 0.05
$ 9.89
+ $ 0.37
$ 7.19
+ $ 0.10
$ 11.08
+ $ 0.07
$ 7.35
- $ 0.51
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 106.0 | 106.0 | 76.3 | 76.0 | 412.5 | 26.7 | 39.0 | 29.5 | 53.0 | 51.8 | 11.0 | 9.7 | 1.7 | |
| Cost of Revenues | 1.7 | 10.8 | 0.0 | 143.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 104.3 | 95.2 | 76.3 | -67.0 | 412.5 | 26.7 | 39.0 | 29.5 | 53.0 | 51.8 | 11.0 | 9.7 | 1.7 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 2.5 | 27.6 | 48.7 | 27.1 | 31.0 | 16.0 | 19.2 | 10.0 | 16.9 | 16.5 | |
| Cost of Revenues | 1.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 25.2 | 32.9 | |
| Gross Profit | 0.8 | 27.6 | 48.7 | 27.1 | 31.0 | 16.0 | 19.2 | 10.0 | -8.3 | -16.4 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 143.6 | 208.6 | 199.8 | 168.5 | 115.9 | 56.7 | 41.7 | 36.8 | 24.7 | 12.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 70.4 | 73.4 | 42.6 | 57.9 | 64.2 | 29.5 | 18.6 | 12.6 | 5.2 | 3.9 | |
| Depreciation & Amortization | -3.3 | 7,725.0 | 11.2 | 17.3 | 12.0 | 9.6 | 10.3 | 1.5 | 3.6 | 2.7 | 1.0 | 0.5 | 0.4 | |
| Total Operating Expenses | 196.8 | 187.7 | 213.4 | 71.1 | 282.0 | 242.3 | 226.4 | 180.1 | 86.1 | 59.2 | 48.1 | 29.6 | 14.4 | |
| Operating Income | -92.5 | -92.5 | -137.1 | -138.1 | 130.5 | -215.6 | -187.5 | -151.3 | -33.1 | -9.0 | -37.9 | -20.0 | -12.7 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 25.5 | 16.5 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.8 | 17.0 | ||
| Depreciation & Amortization | -12.4 | 2.6 | 3.2 | 3.3 | 3.7 | 2.7 | 2.5 | 2.3 | 3.3 | 6.5 | ||
| Total Operating Expenses | 45.0 | 49.7 | 49.4 | 52.7 | 53.2 | 50.2 | 62.1 | 47.8 | 40.3 | 49.7 | ||
| Operating Income | -44.2 | -22.1 | -0.7 | -25.6 | -22.2 | -34.2 | -42.9 | -37.8 | -23.4 | -33.2 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 13.4 | 3,525.6 | 19.9 | 19.7 | 3.6 | 2.0 | 5.7 | 6.0 | 2.6 | 0.7 | 0.3 | 0.3 | 0.1 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 3.6 | 0.0 | 0.0 | 0.0 | 0.2 | 0.9 | 1.0 | 0.0 | 0.0 | |
| Other Expense | 12.8 | 12.8 | 20.5 | 18.8 | 4.7 | 3.3 | 7.3 | 5.3 | -1.3 | -2.5 | -1.1 | 0.5 | -0.3 | |
| IBT | -79.8 | -79.8 | -116.6 | -119.2 | 135.2 | -212.4 | -180.1 | -146.0 | -34.4 | -10.0 | -38.9 | -19.1 | -12.9 | |
| Income Tax Expense | 1.4 | 1.4 | 6.1 | -0.6 | 10.9 | -0.5 | 0.4 | -0.6 | 2.2 | 0.4 | -5.1 | 0.0 | -0.3 | |
| Net Income | -81.1 | -81.1 | -122.7 | -118.7 | 124.3 | -211.8 | -180.6 | -145.4 | -36.6 | -10.4 | -33.8 | -19.2 | -12.9 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 3.0 | 3.5 | 3.4 | 3.4 | 4.1 | 4.8 | 5.2 | 5.9 | 5.0 | 5.0 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.2 | 0.0 | ||
| Other Expense | 2.7 | 3.8 | 2.8 | 3.5 | 4.4 | 4.6 | 5.3 | 6.2 | 4.2 | 5.7 | ||
| IBT | -41.5 | -18.3 | 2.1 | -22.1 | -17.8 | -29.6 | -37.6 | -31.6 | -19.2 | -27.6 | ||
| Income Tax Expense | -0.3 | 1.3 | -0.2 | 0.5 | 5.7 | 0.2 | 0.1 | 0.1 | -4.7 | -1.1 | ||
| Net Income | -41.2 | -19.6 | 2.3 | -22.6 | -23.5 | -29.9 | -37.7 | -31.7 | -14.5 | -28.7 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.72 | $1.91 | $-4.11 | $-3.58 | $-3.83 | $-1.26 | $-0.49 | $-1.72 | $-0.97 | $-0.65 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.72 | $1.90 | $-4.06 | $-3.58 | $-3.83 | $-1.26 | $-0.49 | $-1.72 | $-0.97 | $-0.65 | |
| Shares Outstanding | 75.3 | 75.3 | 75.8 | 68.9 | 65.2 | 51.6 | 50.4 | 38.0 | 29.1 | 21.2 | 19.7 | 19.8 | 19.8 | |
| Diluted Shares Outstanding | 75.3 | 75.3 | 75.9 | 68.9 | 65.2 | 52.1 | 50.4 | 38.0 | 29.1 | 21.3 | 19.7 | 19.8 | 19.8 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.20 | $-0.41 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.20 | $-0.41 | ||
| Shares Outstanding | 75.3 | 75.8 | 75.3 | 75.2 | 75.8 | 76.1 | 76.4 | 76.2 | 70.8 | 70.0 | ||
| Diluted Shares Outstanding | 75.3 | 75.8 | 77.4 | 75.2 | 75.9 | 76.2 | 76.4 | 76.2 | 70.8 | 70.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 71.0 | 66.1 | 157.6 | 400.9 | 201.9 | 242.0 | 128.5 | 42.2 | 35.9 | 16.4 | 11.5 | |
| Short Term Investments | 259.2 | 159.7 | 216.8 | 91.3 | 50.7 | 184.3 | 170.5 | 158.0 | 51.9 | 23.8 | 3.6 | |
| Total Cash & ST Investments | 330.1 | 225.8 | 374.3 | 492.2 | 252.6 | 426.4 | 298.9 | 200.2 | 87.8 | 40.3 | 15.2 | |
| Accounts Receivable | 32.1 | 55.8 | 19.5 | 33.4 | 15.6 | 15.3 | 2.2 | 1.4 | 2.3 | 4.3 | 2.3 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 21.3 | 18.9 | 19.1 | 19.1 | 20.0 | 13.4 | 10.7 | 2.9 | 2.2 | 1.9 | 0.3 | |
| Total Current Assets | 383.5 | 300.5 | 412.9 | 544.7 | 288.2 | 455.1 | 311.8 | 204.4 | 92.3 | 46.5 | 17.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 64.8 | 98.3 | 76.2 | 66.1 | 122.4 | 71.0 | 114.8 | 157.6 | 94.3 | 142.1 | |
| Short Term Investments | 187.1 | 183.1 | 189.1 | 159.7 | 174.8 | 259.2 | 230.2 | 216.8 | 201.1 | 198.0 | |
| Total Cash & ST Investments | 251.9 | 281.4 | 265.3 | 225.8 | 297.2 | 330.1 | 345.0 | 374.3 | 295.4 | 340.1 | |
| Accounts Receivable | 29.4 | 2.6 | 24.6 | 55.8 | 23.7 | 32.1 | 30.9 | 19.5 | 67.3 | 48.8 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 10.4 | 12.1 | 16.6 | 18.9 | 22.9 | 21.3 | 17.8 | 19.1 | 12.0 | 31.4 | |
| Total Current Assets | 291.7 | 296.1 | 306.5 | 300.5 | 343.8 | 383.5 | 393.8 | 412.9 | 374.6 | 420.3 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 35.7 | 34.3 | 37.5 | 47.7 | 49.8 | 17.6 | 16.5 | 6.5 | 7.2 | 6.7 | 0.8 | |
| Goodwill | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 0.0 | |
| Intangible Assets | 7.5 | 4.6 | 25.3 | 26.4 | 21.5 | 22.9 | 23.7 | 20.0 | 19.1 | 20.6 | 0.1 | |
| Long-Term Investments | 65.8 | 98.4 | 82.1 | 0.9 | 0.9 | 25.9 | 0.0 | 0.0 | 0.0 | 0.0 | 4.2 | |
| Other Long-Term Assets | 7.2 | 8.9 | 7.3 | 15.7 | 13.7 | 3.1 | 3.0 | 1.4 | 1.2 | 3.0 | 0.4 | |
| Total Long-Term Assets | 132.1 | 162.6 | 168.0 | 104.0 | 100.9 | 83.3 | 56.4 | 40.0 | 39.6 | 47.5 | 5.5 | |
| Total Assets | 515.6 | 463.1 | 580.9 | 648.7 | 389.1 | 538.4 | 368.2 | 244.4 | 132.0 | 94.0 | 23.1 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 32.5 | 32.6 | 33.4 | 34.3 | 35.7 | 35.7 | 36.0 | 37.5 | 38.8 | 43.2 | |
| Goodwill | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 | |
| Intangible Assets | 1.4 | 2.0 | 3.4 | 4.6 | 6.6 | 7.5 | 25.1 | 25.3 | 8.0 | 25.0 | |
| Long-Term Investments | 47.4 | 52.0 | 56.3 | 98.4 | 77.7 | 65.8 | 75.4 | 82.1 | 95.7 | 92.2 | |
| Other Long-Term Assets | 7.4 | 8.9 | 9.1 | 8.9 | 7.2 | 7.2 | 7.7 | 7.3 | 26.0 | 7.9 | |
| Total Long-Term Assets | 105.6 | 112.3 | 119.1 | 162.6 | 143.4 | 132.1 | 159.9 | 168.0 | 181.7 | 181.7 | |
| Total Assets | 397.3 | 408.4 | 425.5 | 463.1 | 487.2 | 515.6 | 553.8 | 580.9 | 556.4 | 602.1 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.7 | 3.9 | 6.2 | 7.9 | 5.2 | 6.2 | 5.3 | 2.6 | 1.7 | 3.0 | 2.1 | |
| Short-Term Debt | 2.8 | 2.7 | 30.1 | 3.3 | 1.3 | 2.7 | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 44.6 | 54.7 | 39.8 | 82.1 | 7.8 | 39.3 | 45.6 | 23.8 | 5.4 | 6.8 | 0.0 | |
| Current Liabilities | 54.7 | 88.3 | 55.8 | 95.6 | 71.9 | 85.7 | 82.6 | 30.0 | 14.7 | 16.6 | 4.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.3 | 0.0 | 5.2 | 3.9 | 3.4 | 1.7 | 2.5 | 6.2 | 11.0 | 14.5 | |
| Short-Term Debt | 3.4 | 3.6 | 3.3 | 2.7 | 2.9 | 2.8 | 4.2 | 4.3 | 3.8 | 7.3 | |
| Other Current Liabilities | 34.1 | 31.0 | 33.0 | 54.7 | 48.3 | 42.7 | 44.9 | 39.8 | 57.1 | 52.8 | |
| Current Liabilities | 42.0 | 38.5 | 65.1 | 88.3 | 83.9 | 54.7 | 56.9 | 55.8 | 72.8 | 93.5 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 17.2 | 15.8 | 22.5 | 24.8 | 31.0 | 5.9 | 5.6 | 0.0 | 0.1 | 4.4 | 0.0 | |
| Capital Leases | 17.2 | 18.5 | 26.7 | 28.1 | 32.3 | 8.6 | 6.9 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Def. Tax Liability | 3.4 | 4.8 | 3.3 | 1.8 | 1.6 | 1.2 | 0.4 | 0.0 | 0.0 | 5.0 | 0.0 | |
| Total Liabilities | 109.5 | 124.3 | 116.1 | 155.8 | 140.0 | 128.5 | 122.5 | 63.9 | 15.5 | 85.0 | 4.9 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 15.5 | 15.1 | 15.2 | 15.8 | 17.3 | 17.2 | 21.1 | 22.5 | 22.5 | 23.6 | |
| Capital Leases | 0.0 | 18.7 | 18.5 | 18.5 | 20.3 | 17.2 | 25.2 | 26.7 | 26.2 | 27.3 | |
| Def. Tax Liability | 4.8 | 4.9 | 4.8 | 4.8 | 3.5 | 3.4 | 3.4 | 3.3 | 2.0 | 1.9 | |
| Total Liabilities | 77.2 | 73.9 | 100.6 | 124.3 | 120.2 | 109.5 | 115.8 | 116.1 | 132.0 | 153.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1,013.5 | 1,023.8 | 1,006.6 | 906.8 | 741.1 | 724.2 | 450.2 | 320.1 | 223.0 | 106.6 | 83.6 | |
| Retained Earnings | -746.8 | -830.3 | -677.4 | -558.8 | -683.1 | -471.3 | -290.7 | -145.3 | -108.7 | -97.8 | -63.9 | |
| Comprehensive Income | -7.9 | -7.0 | -6.6 | -6.7 | -6.7 | -6.7 | -6.7 | -6.7 | -6.7 | -6.7 | -6.7 | |
| Total Common Equity | 406.2 | 338.8 | 464.8 | 493.0 | 249.1 | 409.9 | -290.7 | -145.3 | 116.4 | 9.0 | 18.2 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1,101.1 | 1,082.3 | 1,030.1 | 1,023.8 | 1,022.5 | 1,013.5 | 1,011.7 | 1,006.6 | 932.1 | 938.7 | |
| Retained Earnings | -886.5 | -850.7 | -853.0 | -830.3 | -797.8 | -746.8 | -709.1 | -677.4 | -663.0 | -634.3 | |
| Comprehensive Income | -6.1 | -6.3 | -6.4 | -7.0 | -6.0 | -7.9 | -7.7 | -6.6 | -8.3 | -7.8 | |
| Total Common Equity | 320.1 | 334.5 | 325.0 | 338.8 | 367.0 | 406.2 | 438.0 | 464.8 | 424.3 | 448.9 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 20.1 | 18.5 | 26.7 | 28.1 | 32.3 | 8.6 | 6.9 | 0.1 | 0.1 | 4.4 | 0.0 | |
| Book Value | 406.2 | 338.8 | 464.8 | 493.0 | 249.1 | 409.9 | 245.7 | 180.5 | 116.4 | 9.0 | 18.2 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 320.1 | 334.5 | 325.0 | 338.8 | 367.0 | 406.2 | 438.0 | 464.8 | 424.3 | 448.9 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -112.5 | -81.1 | -122.7 | -118.7 | 124.3 | -211.8 | -180.6 | -145.4 | -36.6 | -10.4 | -33.8 | -19.2 | -12.9 | |
| Depreciation & Amortization | 14.7 | 10.8 | 11.2 | 17.3 | 12.0 | 9.6 | 10.3 | 7.3 | 3.6 | 2.7 | 1.0 | 0.5 | 0.4 | |
| Stock-Based Compensation | 13.5 | 28.0 | 17.8 | 8.1 | 4.0 | 10.8 | 29.1 | 49.0 | 13.4 | 3.4 | 4.3 | 1.4 | 0.6 | |
| Change Working Capital | -21.2 | 7.5 | -31.0 | -25.5 | 4.0 | 0.4 | -10.1 | 6.4 | 39.9 | 1.8 | -2.4 | -4.9 | 4.6 | |
| Change In Accounts Receivable | 16.8 | 51.2 | -36.4 | 13.9 | -17.5 | -0.3 | -13.1 | -1.8 | -0.1 | 2.4 | -0.6 | -1.4 | -0.3 | |
| Change In Accounts Payable | -26.7 | -23.6 | 14.3 | -44.8 | 26.5 | 16.5 | 7.6 | 21.6 | 3.7 | -0.4 | 1.9 | 2.4 | -1.7 | |
| Change In Inventories | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -9.8 | -0.1 | 0.0 | 0.0 | 1.6 | -0.3 | |
| Other Non-cash Items | 28.6 | 0.8 | 13.9 | 1.3 | -2.2 | -0.4 | -0.4 | 1.5 | 3.8 | 2.7 | 1.1 | 0.0 | 0.3 | |
| Cash from Operations | -90.9 | 0.0 | 0.0 | -118.3 | 144.1 | -192.5 | -151.4 | -81.9 | 24.2 | 0.2 | -35.2 | -22.2 | -7.0 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -41.2 | -19.6 | 2.3 | -22.6 | -23.5 | -29.9 | -37.7 | -31.7 | -14.5 | -28.7 | |
| Depreciation & Amortization | 1.7 | 2.6 | 3.2 | 3.3 | 3.7 | 2.7 | 2.5 | 2.3 | 3.3 | 6.5 | |
| Stock-Based Compensation | -3.4 | 6.9 | 5.9 | 6.4 | 5.0 | 4.7 | 4.6 | 3.6 | 3.4 | 2.0 | |
| Change Working Capital | 18.6 | -20.7 | -0.2 | 10.0 | -26.9 | 16.7 | -10.1 | -10.7 | 21.4 | -22.0 | |
| Change In Accounts Receivable | 24.4 | -26.7 | 22.0 | 31.2 | -31.6 | 7.9 | -1.1 | -11.5 | 47.8 | -18.5 | |
| Change In Accounts Payable | 1.7 | 3.3 | -7.1 | -21.2 | 7.3 | 6.5 | -1.8 | 2.3 | -22.3 | -4.9 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.7 | 16.7 | |
| Other Non-cash Items | 13.0 | -0.5 | 0.7 | 0.0 | -0.9 | 0.1 | 15.9 | -1.2 | 1.3 | -0.7 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.0 | -42.7 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -4.6 | -2.4 | -2.0 | -2.5 | -13.1 | -13.3 | -6.3 | -13.9 | -3.4 | -3.1 | -5.5 | -0.9 | -0.3 | |
| Acquisitions | 7.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.0 | 0.0 | |
| Investments | -363.0 | -196.1 | -283.7 | -553.2 | -40.7 | 0.0 | -50.5 | -11.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 332.2 | 225.1 | 325.6 | 350.1 | -40.7 | 157.9 | 13.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 51.9 | 0.0 | 0.0 | -1.6 | 40.7 | 0.0 | -2.0 | 0.0 | -105.6 | -27.8 | -20.0 | -4.3 | 0.0 | |
| Cash from Investing | -35.5 | 0.0 | 0.0 | -207.3 | -53.8 | 144.6 | -43.4 | -25.6 | -109.0 | -30.9 | -25.5 | -9.2 | -0.3 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.7 | -0.4 | -0.5 | 0.0 | -0.3 | -0.9 | -0.6 | -0.2 | -1.8 | -1.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 | 5.9 | |
| Investments | -55.1 | -35.1 | -70.1 | -34.0 | -53.8 | -52.7 | -110.7 | -66.5 | -61.9 | -125.1 | |
| Sales of Investment | 60.9 | 35.8 | 79.8 | 46.6 | 47.9 | 125.9 | 91.9 | 59.8 | 62.3 | 119.2 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.4 | -5.9 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.3 | -7.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.8 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | -7.2 | 18.5 | -8.2 | -1.4 | -4.2 | 23.7 | 1.8 | 6.9 | 0.0 | 3.5 | 4.4 | 0.0 | 0.0 | |
| Issuance of Common Stock | 55.0 | 0.0 | 0.0 | 76.1 | 107.5 | 0.0 | 300.9 | 188.2 | 90.8 | 55.8 | 0.0 | 1.8 | 46.3 | |
| Repurchase of Common Stock | 820.2 | -41.7 | -30.1 | 0.0 | 1.4 | 2.1 | 1.1 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.1 | -0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 4.3 | 0.0 | 0.0 | 5.8 | -0.3 | 6.0 | 8.1 | 5.4 | 0.7 | 2.0 | 64.8 | -0.2 | 0.1 | |
| Cash from Financing | 55.7 | 0.0 | 0.0 | 81.8 | 108.6 | 8.0 | 309.0 | 193.7 | 91.4 | 50.0 | 64.8 | 1.5 | 46.4 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 18.9 | 0.2 | 0.2 | 0.0 | -1.7 | 0.2 | -5.2 | -1.5 | 0.5 | -1.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 49.9 | 1.9 | |
| Repurchase of Common Stock | -25.3 | 0.0 | 0.0 | 0.0 | -9.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 1.9 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 50.6 | 1.9 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -71.1 | -24.9 | -91.5 | -243.4 | 199.0 | -40.2 | 113.6 | 86.2 | 6.3 | 19.5 | 4.9 | -35.3 | 37.8 | |
| Closing Cash Balance | 71.0 | 41.2 | 66.1 | 157.6 | 400.9 | 201.9 | 242.0 | 128.5 | 42.2 | 35.9 | 16.4 | 11.5 | 46.8 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -23.7 | -33.4 | 22.0 | 10.1 | -56.3 | 51.4 | -43.9 | -42.7 | 63.2 | -47.8 | |
| Closing Cash Balance | 41.2 | 64.8 | 98.3 | 76.2 | 66.1 | 122.4 | 71.0 | 114.8 | 157.6 | 94.3 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -95.6 | -34.5 | -113.1 | -122.4 | 131.0 | -205.7 | -157.7 | -95.7 | 20.8 | -2.9 | -40.7 | -23.0 | -7.3 | |
| Real Free Cash Flow | -109.1 | -62.6 | -130.9 | -130.5 | 127.0 | -216.5 | -186.8 | -144.7 | 7.3 | -6.3 | -45.0 | -24.4 | -7.9 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.6 | -31.8 | 11.2 | -3.7 | -41.8 | -6.9 | -26.1 | -38.3 | 12.2 | -43.8 | |
| Real Free Cash Flow | -7.1 | -38.7 | 5.3 | -10.1 | -46.8 | -11.5 | -30.6 | -41.9 | 8.8 | -45.8 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -21.7 | -11 | -1.4 |
| P/S | 16.6 | 25.5 | 9.4 |
| P/B | 5.5 | 2.5 | 5.2 |
| P/FCF | -34.7 | 3.4 | -1.5 |
| Market cap | $1.3 | $2,194.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 4.8 % | 3.3 % | 0 % |
| Debt to Income | -23.3 % | -7.2 % | 0 % |
| Debt to Free cash flow | -37.3 % | -41729.5 % | 0 % |
| Interest expense percentage | 0 % | -2.6 % | 44.7 % |
| Current ratio | 6.9 | 4.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -25.3 % | -24.7 % | 0 % |
| ROA | -20.4 % | -22.8 % | 0 % |
| CapEx to Revenue | 0.9 % | 27.1 % | 0 % |
| RaD to Revenue | 0 % | 2947.2 % | 0 % |
| ROEM | 370,507.0 | 90350.8 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 100 % | 69.6 % | 68.7 % |
| Operating margin | -52.5 % | -461 % | 35.5 % |
| Net margin | -47.2 % | -380.5 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 6 % | 0 % |
| Dividend payout percentage | 0 % | -70.1 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 75.8 mil | 48.5 mil |
| Employee count | 0.3 tis | 0.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
